Global Novel Oral AntiCoagulants (NOAC) Market Survey and Trend Research 2018

September 2018 | 76 pages | ID: G55E7296602EN
99Strategy

Abstracts

Summary

This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.

Industry Chain

• Raw Materials
• Cost
• Technology
• Consumer Preference

Industry Overall:

• History
• Development & Trend
• Market Competition
• Trade Overview
• Policy

Region (North America, Europe, Asia-Pacific, South America, Middle East, Africa):

• Regional Market
• Production Development
• Sales
• Regional Trade
• Regional Forecast

Company (Johnson & Johnson, Bristol-Myers Squibb, Boehringer Ingelheim, Sanofi, Armatheon, Armatheon, Aspen, AstraZeneca, Bayer, Cellceutix, Cosmo Pharmaceuticals, CSL Behring, Eisai, GSK, Marathon Pharmaceuticals, Ockham Biotech, Perosphere etc.):

• Company Profile
• Product & Service
• Business Operation Data
• Market Share

Investment Analysis:

• Market Features
• Investment Opportunity
• Investment Calculation

Contents

PART 1 INDUSTRY OVERVIEW

1.1 Novel Oral AntiCoagulants (NOAC) Industry
  1.1.1 Definition
  1.1.2 Industry Trend
1.2 Industry Chain
  1.2.1 Upstream
  1.2.2 Technology
  1.2.3 Cost Structure
  1.2.4 Consumer Preference
  1.2.2 Downstream

PART 2 INDUSTRY OVERALL

2.1 Industry History
2.2 Development Prospect
2.3 Competition Structure
2.4 Relevant Policy
2.5 Trade Overview

PART 3 NOVEL ORAL ANTICOAGULANTS (NOAC) MARKET BY PRODUCT

3.1 Products List of Major Companies
3.2 Market Size
3.3 Market Forecast

4 KEY COMPANIES LIST

4.1 Johnson & Johnson (Company Overview, Sales Data etc.)
  4.1.1 Company Overview
  4.1.2 Products and Services
  4.1.3 Business Analysis
4.2 Bristol-Myers Squibb (Company Overview, Sales Data etc.)
  4.2.1 Company Overview
  4.2.2 Products and Services
  4.2.3 Business Analysis
4.3 Boehringer Ingelheim (Company Overview, Sales Data etc.)
  4.3.1 Company Overview
  4.3.2 Products and Services
  4.3.3 Business Analysis
4.4 Sanofi (Company Overview, Sales Data etc.)
  4.4.1 Company Overview
  4.4.2 Products and Services
  4.4.3 Business Analysis
4.5 Armatheon (Company Overview, Sales Data etc.)
  4.5.1 Company Overview
  4.5.2 Products and Services
  4.5.3 Business Analysis
4.6 Armatheon (Company Overview, Sales Data etc.)
  4.6.1 Company Overview
  4.6.2 Products and Services
  4.6.3 Business Analysis
4.7 Aspen (Company Overview, Sales Data etc.)
  4.7.1 Company Overview
  4.7.2 Products and Services
  4.7.3 Business Analysis
4.8 AstraZeneca (Company Overview, Sales Data etc.)
  4.8.1 Company Overview
  4.8.2 Products and Services
  4.8.3 Business Analysis
4.9 Bayer (Company Overview, Sales Data etc.)
  4.9.1 Company Overview
  4.9.2 Products and Services
  4.9.3 Business Analysis
4.10 Cellceutix (Company Overview, Sales Data etc.)
  4.10.1 Company Overview
  4.10.2 Products and Services
  4.10.3 Business Analysis
4.11 Cosmo Pharmaceuticals (Company Overview, Sales Data etc.)
4.12 CSL Behring (Company Overview, Sales Data etc.)
4.13 Eisai (Company Overview, Sales Data etc.)
4.14 GSK (Company Overview, Sales Data etc.)
4.15 Marathon Pharmaceuticals (Company Overview, Sales Data etc.)
4.16 Ockham Biotech (Company Overview, Sales Data etc.)
4.17 Perosphere (Company Overview, Sales Data etc.)

PART 5 MARKET COMPETITION

5.1 Companies Competition
5.2 Industry Competition Structure Analysis
  5.2.1 Rivalry
  5.2.2 Threat of New Entrants
  5.2.3 Substitutes
  5.2.4 Bargaining Power of Suppliers
  5.2.5 Bargaining Power of Buyers

PART 6 MARKET DEMAND BY SEGMENT

6.1 Demand Situation
  6.1.1 Industry Application Status
  6.1.2 Industry SWOT Analysis
    6.1.2.1 Strengths
    6.1.2.2 Weaknesses
    6.1.2.3 Opportunities
    6.1.2.4 Threats
6.2 Major Customer Survey
6.3 Demand Forecast

PART 7 REGION OPERATION

7.1 Regional Market
7.2 Production and Sales by Region
  7.2.1 Production
  7.2.2 Sales
  7.2.3 Trade
7.3 Regional Forecast

PART 8 MARKET INVESTMENT

8.1 Market Features
  8.1.1 Product Features
  8.1.2 Price Features
  8.1.3 Channel Features
  8.1.4 Purchasing Features
8.2 Investment Opportunity
  8.2.1 Regional Investment Opportunity
  8.2.2 Industry Investment Opportunity
8.3 Investment Calculation
  8.3.1 Cost Calculation
  8.3.2 Revenue Calculation
  8.3.3 Economic Performance Evaluation

PART 9 CONCLUSION

List Of Tables

LIST OF TABLES

Table Global Novel Oral AntiCoagulants (NOAC) Market 2012-2017, by Type, in USD Million
Table Global Novel Oral AntiCoagulants (NOAC) Market Forecast 2018-2023, by Type, in USD Million
Table Johnson & Johnson Overview List
Table Novel Oral AntiCoagulants (NOAC) Business Operation of Johnson & Johnson (Sales Revenue, Cost, Gross Margin)
Table Bristol-Myers Squibb Overview List
Table Novel Oral AntiCoagulants (NOAC) Business Operation of Bristol-Myers Squibb (Sales Revenue, Cost, Gross Margin)
Table Boehringer Ingelheim Overview List
Table Novel Oral AntiCoagulants (NOAC) Business Operation of Boehringer Ingelheim (Sales Revenue, Cost, Gross Margin)
Table Sanofi Overview List
Table Novel Oral AntiCoagulants (NOAC) Business Operation of Sanofi (Sales Revenue, Cost, Gross Margin)
Table Armatheon Overview List
Table Novel Oral AntiCoagulants (NOAC) Business Operation of Armatheon (Sales Revenue, Cost, Gross Margin)
Table Armatheon Overview List
Table Novel Oral AntiCoagulants (NOAC) Business Operation of Armatheon (Sales Revenue, Cost, Gross Margin)
Table Aspen Overview List
Table Novel Oral AntiCoagulants (NOAC) Business Operation of Aspen (Sales Revenue, Cost, Gross Margin)
Table AstraZeneca Overview List
Table Novel Oral AntiCoagulants (NOAC) Business Operation of AstraZeneca (Sales Revenue, Cost, Gross Margin)
Table Bayer Overview List
Table Novel Oral AntiCoagulants (NOAC) Business Operation of Bayer (Sales Revenue, Cost, Gross Margin)
Table Cellceutix Overview List
Table Novel Oral AntiCoagulants (NOAC) Business Operation of Cellceutix (Sales Revenue, Cost, Gross Margin)
Table Cosmo Pharmaceuticals Overview List
Table Novel Oral AntiCoagulants (NOAC) Business Operation of Cosmo Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
Table CSL Behring Overview List
Table Novel Oral AntiCoagulants (NOAC) Business Operation of CSL Behring (Sales Revenue, Cost, Gross Margin)
Table Eisai Overview List
Table Novel Oral AntiCoagulants (NOAC) Business Operation of Eisai (Sales Revenue, Cost, Gross Margin)
Table GSK Overview List
Table Novel Oral AntiCoagulants (NOAC) Business Operation of GSK (Sales Revenue, Cost, Gross Margin)
Table Marathon Pharmaceuticals Overview List
Table Novel Oral AntiCoagulants (NOAC) Business Operation of Marathon Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
Table Ockham Biotech Overview List
Table Novel Oral AntiCoagulants (NOAC) Business Operation of Ockham Biotech (Sales Revenue, Cost, Gross Margin)
Table Perosphere Overview List
Table Novel Oral AntiCoagulants (NOAC) Business Operation of Perosphere (Sales Revenue, Cost, Gross Margin)
Table Global Novel Oral AntiCoagulants (NOAC) Sales Revenue 2012-2017, by Companies, in USD Million
Table Global Novel Oral AntiCoagulants (NOAC) Sales Revenue Share, by Companies, in USD Million
Table Novel Oral AntiCoagulants (NOAC) Demand 2012-2017, by Application, in USD Million
Table Novel Oral AntiCoagulants (NOAC) Demand Forecast 2018-2023, by Application, in USD Million
Table Global Novel Oral AntiCoagulants (NOAC) Market 2012-2017, by Region, in USD Million
Table Novel Oral AntiCoagulants (NOAC) Market Forecast 2018-2023, by Region, in USD Million

List Of Figures

LIST OF FIGURES

Figure Novel Oral AntiCoagulants (NOAC) Industry Chain Structure
Figure Global Novel Oral AntiCoagulants (NOAC) Market Growth 2012-2017, by Type, in USD Million
Figure Global Novel Oral AntiCoagulants (NOAC) Sales Revenue Share, by Companies in 2017, in USD Million
Figure Production Development by Region
Figure Sales List by Region